Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma.

Seok Jin KimDanbee KangYong ParkYeung-Chul MunKihyun KimJin Seok KimChang-Ki MinJuhee Cho

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)

Patients with depression had a substantially high risk of poor adherence compared to patients without depression. Given that Rd treatment is mainly offered by outpatient clinics, active interventions to reduce depression should be considered for MM patients prior to Rd treatment.

Keyphrases

newly diagnosed
low dose
end stage renal disease
depressive symptoms
ejection fraction
chronic kidney disease
multiple myeloma
sleep quality
prognostic factors
primary care
acute myeloid leukemia
type diabetes
combination therapy
glycemic control
patient reported
chronic lymphocytic leukemia